Jennifer L. Marté

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

Julius Strauss, Christopher R. Heery, Jeffrey Schlom et al. · Clinical Cancer Research · 2018 · 415 citations · Full text

Medicine, Oncology, Pharmacology +17

Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer

James L. Gulley, Philip M. Arlen, Anne Bastian et al. · Clinical Cancer Research · 2005 · 371 citations

Medicine, Oncology, Radiation Oncology +17

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Fatima Karzai, David James VanderWeele, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2018 · 312 citations · Full text

Medicine, Oncology, Pharmacology +17

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Christopher R. Heery, Geraldine O’Sullivan Coyne, Ravi A. Madan et al. · The Lancet Oncology · 2017 · 295 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

Philip M. Arlen, James L. Gulley, Catherine Parker et al. · Clinical Cancer Research · 2006 · 291 citations · Full text

Medicine, Oncology, Pharmacology +17